Product logins

Find logins to all Clarivate products below.


John Lebbos

Partner, Commercial Strategy Consulting

John Lebbos, MD is a Partner in Clarivate’s Commercial Strategy Consulting team.​​​

He is currently a practice leader in Product and Market Opportunity Assessments & Strategy and has over 20 years of experience supporting clients with product and therapeutic area strategy, functional patient journey analysis, opportunity and market assessments, disease area analysis, sales forecasting, and portfolio planning/strategy.​​

Formerly a Vice President in DRG’s infectious disease syndicated research group, Dr. Lebbos led the Infectious Disease research team and has had over 20 years of experience conducting market analysis, opportunity assessments and prioritization and product strategy. ​​

Dr. Lebbos received his medical degree from the University of Massachusetts. Prior to pursuing his medical degree, he attended Tufts University where he graduated summa cum laude in chemical engineering.


arrow_forward
Get in touch with John

Latest news

News January 28, 2026
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…

News January 22, 2026
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources

Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…

News January 21, 2026
Clarivate Reveals Top 100 Global Innovators 2026

The Top 100 organizations lead the way in innovation, contributing an exceptional 16% of the world’s highest-strength AI inventions London, U.K. January, 21, 2026. Clarivate Plc (NYSE:CLVT), a leading global…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025